-The Indian Express Vietnam is by far the largest importer, data show; it is likely, however, that the bulk of the over 6 lakh tonnes of carabeef shipped to Vietnam finds its way unofficially to China Brazil and India have been vying for the top spot in world beef exports over the past several years. In 2014, India dislodged Brazil from the number 1 slot, according to United States Department of Agriculture...
More »SEARCH RESULT
Five reasons why Aadhaar shouldn't be applied universally -Mitali Saran
-Business Standard Not only is your privacy stripped stark naked, the system itself is illegal and vulnerable Indians have serious red tape PTSD. We live with chronic anxiety about the documents that get us the entitlements and paid services we need — food, cooking gas, SIM cards, sale deeds, passports and so on. We’re so tyrannised by bureaucracy that when we hear of an official document that might simplify life, we fall...
More »It's the technology, stupid -Sunil Abraham
-The Hindu Business Line Eleven reasons why the Aadhaar is not just non-smart but also insecure Aadhaar is insecure because it is based on biometrics. Biometrics is surveillance technology, a necessity for any State. However, surveillance is much like salt in cooking: essential in tiny quantities, but counterproductive even if slightly in excess. Biometrics should be used for targeted surveillance, but this technology should not be used in e-governance for the following...
More »Arid land yields a bounty of succulent fruits -Azera Parveen Rahman
-The Hindu Business Line Kutch presents an example of robust desert horticulture Over the past decade, the total horticultural land under cultivation of fruits such as pomegranate, mango and date palm has doubled in Kutch and its fruit production has trebled. And why is this a surprise? Because this semi-arid region in Kutch has, through 10 years of toil, transformed the landscape and set an innovative example in desert horticulture. Adversity, they say, can...
More »The high price of Big Pharma greed -Leena Menghaney
-The Hindu In 2014, an Indian pharmaceutical company was globally the first to receive approval to market a biosimilar, thereby affordable version, of the breast cancer drug Trastuzumab. Almost immediately, Swiss pharmaceutical company Roche, innovator of the drug, filed a suit against the Indian Food & Drug Administration (FDA) to block its sale. The action firmly put their profits ahead of the lives of women with breast cancer. Roche effectively embroiled India’s...
More »